Menu Search
Equities

China Health Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8225:HKG.HS

China Health Group Inc

Actions
  • Price (HKD)0.14
  • Today's Change0.00 / 0.00%
  • Shares traded60.00k
  • 1 Year change-21.35%
  • Beta0.1246
Data delayed at least 15 minutes, as of Feb 05 2026 01:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Health Group Inc is an investment holding company primarily engaged in the provision of post-marketing research and academic extension services. The Company's services include hospital big data clinical research, digital research product promotion services, jointly build digital research and development clinical research specialties, specialized medical and pharmaceutical services,special specialty medical drug clinic, rehabilitation medical and travel medical services. The Company's business mainly covers the fields of mental health and psychological well-being, neuroscience and chronic disease management, and allergy and respiratory diseases.

  • Revenue in HKD (TTM)33.52m
  • Net income in HKD-14.83m
  • Incorporated2002
  • Employees44.00
  • Location
    China Health Group IncBlock 17Jianwai SOHO, Chaoyang DistrictBEIJING 100089ChinaCHN
  • Websitehttp://www.chgi.net
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.